Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

BTAI

BTAI News

Newswire

04:27

BioXcel Therapeutics: Analysts Update Price Target to $16.75, Mizuho Raises Estimate to $390M.

07:08

BioXcel Therapeutics hosts virtual roundtable on self-administered bipolar treatment.

07:02

Virtual Roundtable to Discuss Latest Developments in Treating Acute Agitation Related to Neuropsychiatric Conditions

13:52

BioXcel Therapeutics Receives FDA Approval for New Indication of Igalmi, Faces Significant Financial Challenges

12:20

BioXcel Therapeutics Price Target Increased to $21.83, Up 15.68%

View More

About BTAI

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More